Abbott Laboratories ROA 2006-2018 | ABT
Current and historical return on assets (ROA) values for Abbott Laboratories (ABT) over the last 10 years.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.003B | $27.390B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $119.437B | 18.49 |
| Stryker (SYK) | United States | $65.138B | 26.05 |
| Boston Scientific (BSX) | United States | $46.017B | 25.65 |
| Baxter (BAX) | United States | $40.044B | 28.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.354B | 14.71 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.749B | 0.00 |
| ResMed (RMD) | United States | $15.576B | 32.57 |
| Perrigo (PRGO) | Ireland | $10.509B | 14.74 |
| Bio-Rad Laboratories (BIO) | United States | $9.059B | 73.06 |
| Canopy Growth (CGC) | Canada | $6.194B | 0.00 |
| ICU Medical (ICUI) | United States | $6.080B | 56.57 |
| Hill-Rom Holdings (HRC) | United States | $6.049B | 21.73 |
| Agios Pharmaceuticals (AGIO) | United States | $5.208B | 0.00 |
| Insulet (PODD) | United States | $5.056B | 0.00 |
| Haemonetics (HAE) | United States | $4.936B | 50.83 |
| Neogen (NEOG) | United States | $4.230B | 73.06 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.215B | 0.00 |
| Hutchison China MediTech (HCM) | China | $4.211B | 0.00 |
| National Vision Holdings (EYE) | United States | $3.003B | 0.00 |
| NuVasive (NUVA) | United States | $2.762B | 27.92 |
| Quidel (QDEL) | United States | $2.591B | 113.39 |
| Phibro Animal Health (PAHC) | United States | $1.950B | 28.95 |
| Abaxis,Inc (ABAX) | United States | $1.905B | 64.06 |
| NxStage Medical (NXTM) | United States | $1.862B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.425B | 21.95 |
| Eagle Pharmaceuticals (EGRX) | United States | $1.182B | 33.05 |
| Cardiovascular Systems (CSII) | United States | $1.163B | 0.00 |
| Orthofix (OFIX) | $1.090B | 33.20 | |
| Owens & Minor (OMI) | United States | $1.070B | 10.76 |
| OraSure Technologies (OSUR) | United States | $1.056B | 64.07 |
| TG Therapeutics (TGTX) | United States | $1.049B | 0.00 |
| AtriCure (ATRC) | United States | $1.015B | 0.00 |
| Omeros (OMER) | United States | $1.015B | 0.00 |
| Cerus (CERS) | United States | $0.949B | 0.00 |
| MacroGenics (MGNX) | United States | $0.925B | 0.00 |
| Surmodics (SRDX) | United States | $0.793B | 136.02 |
| LeMaitre Vascular (LMAT) | United States | $0.706B | 41.55 |
| Meridian Bioscience (VIVO) | United States | $0.665B | 23.43 |
| PetIQ (PETQ) | United States | $0.630B | 0.00 |
| Evolus (EOLS) | United States | $0.619B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.565B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.538B | 14.05 |
| Surface Oncology (SURF) | United States | $0.447B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.387B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.375B | 24.79 |
| Cytosorbents (CTSO) | United States | $0.371B | 0.00 |
| Quanterix (QTRX) | United States | $0.330B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.280B | 0.00 |
| Chimerix (CMRX) | United States | $0.226B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.221B | 0.00 |
| Fonar (FONR) | United States | $0.178B | 10.80 |
| Bovie Medical (BVX) | United States | $0.169B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.158B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.140B | 0.00 |
| Female Health (VERU) | United States | $0.111B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.102B | 30.31 |
| United-Guardian (UG) | United States | $0.090B | 20.97 |
| Neurotrope (NTRP) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.087B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.076B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.057B | 0.00 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.047B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.043B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.029B | 0.00 |
| Myomo (MYO) | United States | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.027B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.010B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.003B | 0.00 |
